|
1
|
Faderl S, Talpaz M, Estrov Z, O'Brien S,
Kurzrock R and Kantarjian HM: The biology of chronic myeloid
leukemia. N Engl J Med. 341:164–172. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fielding AK: How I treat Philadelphia
chromosome-positive acute lymphoblastic leukemia. Blood.
116:3409–3417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deschler B and Lübbert M: Acute myeloid
leukemia: Epidemiology and etiology. Cancer. 107:2099–2107. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vardiman JW, Thiele J, Arber DA, Brunning
RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM,
Hellström-Lindberg E, Tefferi A and Bloomfield CD: The 2008
revision of the World Health Organization (WHO) classification of
myeloid neoplasms and acute leukemia: Rationale and important
changes. Blood. 114:937–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paietta E, Racevskis J, Bennett JM,
Neuberg D, Cassileth PA, Rowe JM and Wiernik PH: Biologic
heterogeneity in Philadelphia chromosome-positive acute leukemia
with myeloid morphology: The eastern cooperative oncology group
experience. Leukemia. 12:1881–1885. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Keung YK, Beaty M, Powell BL, Molnar I,
Buss D and Pettenati M: Philadelphia chromosome positive
myelodysplastic syndrome and acute myeloid leukemia-retrospective
study and review of literature. Leuk Res. 28:579–586. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berger R: Differences between blastic
chronic myeloid leukemia and Ph-positive acute leukemia. Leuk
Lymphoma. 11:(Suppl 1). 235–237. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soupir CP, Vergilio JA, Dal Cin P,
Muzikansky A, Kantarjian H, Jones D and Hasserjian RP: Philadelphia
chromosome-positive acute myeloid leukemia: A rare aggressive
leukemia with clinicopathologic features distinct from chronic
myeloid leukemia in myeloid blast crisis. Am J Clin Pathol.
127:642–650. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cuneo A, Ferrant A, Michaux JL, Demuynck
H, Boogaerts M, Louwagie A, Doyen C, Stul M, Cassiman JJ, Dal Cin
P, et al: Philadelphia chromosome-positive acute myeloid leukemia:
Cytoimmunologic and cytogenetic features. Haematologica.
81:423–427. 1996.PubMed/NCBI
|
|
10
|
Konoplev S, Yin CC, Kornblau SM,
Kantarjian HM, Konopleva M, Andreeff M, Lu G, Zuo Z, Luthra R,
Medeiros LJ and Bueso-Ramos CE: Molecular characterization of De
novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk
Lymphoma. 54:138–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nacheva EP, Grace CD, Brazma D, Gancheva
K, Howard-Reeves J, Rai L, Gale RE, Linch DC, Hills RK, Russell N,
et al: Does BCR/ABL1 positive acute myeloid leukaemia exist? Br J
Haematol. 161:541–550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ito K, Tominaga K, Suzuki T, Jinnai I and
Bessho M: Successful treatment with imatinib mesylate in a case of
minor BCR-ABL-positive acute myelogenous leukemia. Int J Hematol.
81:242–245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jentsch-Ullrich K, Pelz AF, Braun H,
Koenigsmann M, Mohren M, Wieacker P and Franke A: Complete
molecular remission in a patient with Philadelphia-chromosome
positive acute myeloid leukemia after conventional therapy and
imatinib. Haematologica. 89:ECR152004.PubMed/NCBI
|
|
14
|
Yamaguchi M and Konishi I: Successful
treatment with imatinib mesylate for Philadelphia
chromosome-positive refractory acute myeloid leukemia. Rinsho
Ketsueki. 44:254–256. 2003.PubMed/NCBI
|
|
15
|
Lazarevici V, Golovleva I, Nygren I and
Wahlin A: Induction chemotherapy and post-remission Imatinib
therapy for De novo BCR-ABL positive AML. Am J Hematol. 81:470–471.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kondo T, Tasaka T, Sano F, Matsuda K, Kubo
Y, Matsuhashi Y, Nakanishi H, Sadahira Y, Wada H, Sugihara T and
Tohyama K: Philadelphia chromosome-positive acute myeloid leukemia
(Ph +AML) treated with imatinib mesylate (IM): A report with IM
plasma concentration and bcr-abl transcripts. Leuk Res.
33:e137–e138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun J, Wang Z, Luo Y, Tan Y, Allan DS and
Huang H: Prolonged survival with imatinib mesylate combined with
chemotherapy and allogeneic stem cell transplantation in De novo
Ph+ acute myeloid leukemia. Acta Haematol. 127:143–148. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bacher U, Haferlach T, Alpermann T, Zenger
M, Hochhaus A, Beelen DW, Uppenkamp M, Rummel M, Kern W, Schnittger
S and Haferlach C: Subclones with the t(9;22)/BCR-ABL1
rearrangement occur in AML and seem to cooperate with distinct
genetic alterations. Br J Haematol. 152:713–720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kapadia SB and Kaplan SS: Simultaneous
occurrence of non-Hodgkin's lymphoma and acute myelomonocytic
leukemia. Cancer. 38:2557–2560. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Youness E, Ahearn MJ and Drewinko B:
Simultaneous occurrence of non-Hodgkin's lymphoma and spontaneous
acute granulocytic leukemia. Am J Clin Pathol. 70:415–420. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ohwada C, Nakaseko C, Tanaka H, Abe D, Oda
K, Ozawa S, Takeuchi M, Shimizu N, Cho R, Saito Y and Nishimura M:
Successful matched unrelated BMT for secondary AML which developed
simultaneously with relapsed Hodgkin's lymphoma. Bone Marrow
Transplant. 39:569–570. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jaalouk G, Avvisati G, Latagliata R,
Pacchiarotti A, Pulsoni A, Mecarocci S and Malagnino F:
Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and
myelodysplastic syndrome rapidly evolving into acute myeloblastic
leukemia. Leuk Lymphoma. 21:339–341. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Montefusco E, Fazi F, Cordone I, Ariola C,
Nanni M, Spadea A, Spiriti MA, Fenu S, Mandelli F and Petti MC:
Molecular remission following high-dose hydroxyurea and fludarabine
plus cytarabine in a patient with simultaneous acute myeloid
leukemia and low-grade lymphoma. Leuk Lymphoma. 40:671–674. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Janossy G, Woodruff RK, Paxton A, Greaves
MF, Capellaro D, Kirk B, Innes EM, Eden OB, Lewis C, Catovsky D and
Hoffbrand AV: Membrane marker and cell separation studies in
Ph1-positive leukemia. Blood. 51:861–877. 1978.PubMed/NCBI
|
|
25
|
Cauwelier B, Nollet F, De Laere E, Van
Leeuwen M, Billiet J, Criel A and Louwagie A: Simultaneous
occurrence of myelodysplastic syndrome and monoclonal B lymphocytes
with a different clonal origin. Leuk Lymphoma. 43:191–193. 2002.
View Article : Google Scholar : PubMed/NCBI
|
